December 6, 2018
Company Release no. 20/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 06 December 2018   Veloxis Increases Share Capital in Connection with Exercise of Warrants   Veloxis Pharmaceuticals A/S announces that the Company’s capital has been increased by 4,948,055 new shares with a nominal value of DKK 0.10 each corresponding to nominally DKK 494,805.50 as a...
Capital increase without preferential subscription rights to the benefit of certain categories of investors Saint-Priest, France, December 6, 2018, 8:00 (Paris time) – Biom’up (the “Company”), a specialist in surgical hemostasis, announces the success of its private placement financing of €7.67 million through a capital increase by the issuance of new shares without preferential subscription...


Six brain professors receive DKK 232 million
10. December 2019
A system for flagging postpartum depression
19. November 2019
The Lundbeck Foundation awards a record number of fellowships
6. November 2019


Lundbeckfonden Ventures

Lundbeckfonden Emerge